Ji-Ye Kee Selected Research

Ji-Ye Kee Research Topics

Disease

15	Neoplasms (Cancer) 03/2021 - 01/2013
14	Neoplasm Metastasis (Metastasis) 02/2022 - 03/2013
14	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 03/2013
7	Inflammation (Inflammations) 01/2021 - 04/2015
5	Anaphylaxis (Anaphylactic Shock) 04/2019 - 03/2011
3	Obesity 01/2021 - 01/2016
3	Colonic Neoplasms (Colon Cancer) 10/2020 - 12/2016
3	AIDS-Related Complex (ARC) 11/2017 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2020 - 10/2019
2	Melanoma (Melanoma, Malignant) 03/2020 - 01/2017
2	Weight Gain 09/2019 - 01/2016
2	Atopic Dermatitis (Atopic Eczema) 04/2017 - 06/2015
2	Hypersensitivity (Allergy) 04/2015 - 03/2011
1	Chronic Disease (Chronic Diseases) 03/2021
1	Fatigue 11/2020
1	Cachexia 10/2020
1	Atrophy 10/2020
1	Body Weight (Weight, Body) 01/2017
1	Colitis 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Dermatitis 03/2011

Drug/Important Bio-Agent (IBA)

6	p-Methoxy-N-methylphenethylamineIBA 04/2019 - 03/2011
5	Mitogen-Activated Protein KinasesIBA 04/2019 - 06/2015
4	InterleukinsIBA 10/2020 - 06/2015
4	Ethanol (Ethyl Alcohol)IBA 04/2020 - 11/2017
4	Immunoglobulin E (IgE)IBA 04/2019 - 06/2015
4	ChemokinesIBA 04/2017 - 01/2013
3	schizandrol BIBA 01/2021 - 01/2018
3	Anti-Allergic Agents (Antiallergic Agents)IBA 04/2019 - 04/2017
3	arctigeninIBA 11/2017 - 01/2016
3	CytokinesIBA 11/2017 - 06/2015
3	DinitrofluorobenzeneIBA 04/2017 - 03/2011
2	Therapeutic UsesIBA 02/2022 - 01/2017
2	Pharmaceutical PreparationsIBA 10/2019 - 08/2016
2	Cadherins (E-Cadherin)IBA 01/2019 - 08/2016
2	beta-lapachoneIBA 12/2017 - 01/2017
2	Chemokine CXCL16IBA 12/2014 - 03/2013
2	Chemotactic FactorsIBA 03/2013 - 01/2013
1	dehydroevodiamineIBA 02/2022
1	trachelosideIBA 03/2021
1	Oxidants (Oxidizing Agents)IBA 03/2021
1	Tannic Acid FDA Link 01/2021
1	Ellagic AcidIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	yukmijihwang-tangIBA 11/2020
1	Liuwei Dihuang DecoctionIBA 11/2020
1	Hydroxyindoleacetic AcidIBA 11/2020
1	Serotonin (5 Hydroxytryptamine)IBA 11/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020
1	Conditioned Culture MediaIBA 10/2020
1	decursinIBA 04/2020
1	LignansIBA 03/2020
1	betulinIBA 12/2019
1	pyrimidineIBA 10/2019
1	Gemcitabine FDA Link 10/2019
1	NucleosidesIBA 10/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2019
1	Hematoxylin (Haematoxylon)IBA 09/2019
1	LipidsIBA 09/2019
1	ginsenoside Rg3IBA 04/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Rosmarinic AcidIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 11/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2017
1	Interleukin-8 (Interleukin 8)IBA 11/2017
1	NF-kappa B (NF-kB)IBA 04/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	Hypoxia-Inducible Factor 1IBA 01/2017
1	Dextran SulfateIBA 01/2017
1	GelatinIBA 12/2016
1	QuercetinIBA 12/2016
1	Annexin A5IBA 12/2016
1	VimentinIBA 08/2016
1	CateninsIBA 08/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2016
1	AntioxidantsIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2016
1	AMP-Activated Protein KinasesIBA 01/2016
1	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2016
1	PPAR gammaIBA 01/2016
1	Fatty Acid-Binding ProteinsIBA 01/2016
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2016
1	caffeic acidIBA 06/2015
1	moutan cortexIBA 04/2015
1	Chemokine CX3CL1IBA 01/2013
1	Biological ProductsIBA 01/2013

Therapy/Procedure

3	Oral Administration 02/2022 - 11/2020
1	Intraperitoneal Injections 10/2020
1	Subcutaneous Injections 10/2020
1	Traditional Medicine (Folk Remedies) 12/2017
1	Therapeutics 01/2013